Clinical Trial Update: Prolonged or Standard Infusion of Cefepime Hydrochloride in Treating Patients With Febrile Neutropenia [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial updating on prolonged versus standard infusion of cefepime hydrochloride for treating febrile neutropenia in adults.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Febrile Neutropenia
• Neutropenia

Drugs mentioned

• CEFEPIME HYDROCHLORIDE (cefepime hydrochloride)

Snippet

Sponsor: Wake Forest University Health Sciences | Conditions: Adult Acute Lymphoblastic Leukemia, Adult Acute Myeloid Leukemia | Phase 1 | Status: COMPLETED